Treatment and Outcomes of Malignant Melanoma of the Eyelid. A Review of 29 Cases in Australia

Ophthalmology

Volumn 114, Issue 1, 2007, Pages 187-192

  Chan, Fiona M ^a   O'Donnell, Brett A ^b   Whitehead, Kevin ^c   Ryman, William ^b   Sullivan, Timothy J ^a,d  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; EYELID TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MALIGNANT LENTIGO; MELANOMA; PIGMENTATION; PRIORITY JOURNAL; RECURRENT DISEASE; ULCER;

ADULT; AGED; AGED, 80 AND OVER; EYELID NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; MOHS SURGERY; NEW SOUTH WALES; OPHTHALMOLOGIC SURGICAL PROCEDURES; QUEENSLAND; RECONSTRUCTIVE SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33845910114     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.08.043     Document Type: Article

References (35)

1. Queensland Cancer Registry. Cancer in Queensland. Incidence and mortality 1982 to 2003. Statistical tables. Available at: http://www.health.qld.gov.au/hic/qcr2005/1982_03_text.pdf. Accessed November 4, 2006.
2. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172 (1970) 902-908
3. Clark Jr. W., From L., Bernadino E., and Mihm M. The histogenesis and biologic behavior of primary malignant melanomas of the skin. Cancer Res 29 (1969) 705-727
4. Balch C.M., Buzaid A.C., Soong S.J., et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19 (2001) 3635-3648
5. Wong V.A., Marshall J.A., Whitehead K.J., et al. Management of periocular basal cell carcinoma with modified en face frozen section controlled excision. Ophthal Plast Reconstr Surg 18 (2002) 430-435
6. Weedon D. Skin Pathology. 2nd ed. (2002), Churchill Livingstone, London 802-835
7. Grossniklaus H.E., and McLean I.W. Cutaneous melanoma of the eyelid: clinicopathologic features. Ophthalmology 98 (1991) 1867-1873
8. Vaziri M., Buffam F., Martinka M., et al. Clinicopathologic features and behavior of cutaneous eyelid melanoma. Ophthalmology 109 (2002) 901-908
9. Harris T.J., and Hinckley D.M. Melanoma of the head and neck in Queensland. Head Neck Surg 5 (1983) 197-203
10. National Health and Medical Research Council. Clinical practice guidelines. The management of cutaneous melanoma (1999) 25. http://www.nhmrc.gov.au/publications/_files/cp68.pdf Available at: http://www.nhmrc.gov.au/publications/_files/cp68.pdf. Accessed October 16, 2006.
11. Esmaeli B., Wang B., Deavers M., et al. Prognostic factors for survival in malignant melanoma of the eyelid skin. Ophthal Plast Reconstr Surg 16 (2000) 250-257
12. Zoltie N., and O'Neill T.J. Malignant melanomas of eyelid skin. Plast Reconstr Surg 83 (1989) 994-996
13. Garner A., Koornneef L., Levene A., and Collin J.R. Malignant melanoma of the eyelid skin: histopathology and behaviour. Br J Ophthalmol 69 (1985) 180-186
14. Collin J.R., Allen L.H., Garner A., and Hungerford J.L. Malignant melanoma of the eyelid and conjunctiva. Aust N Z J Ophthalmol 14 (1986) 29-34
15. Cook Jr. B.E., and Bartley G.B. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology 108 (2001) 2088-2098
16. Hudson D.A., Krige J.E.J., Grobbelaar A.O., et al. Melanoma of the face: the safety of narrow excision margins. Scand J Plast Reconstr Surg Hand Surg 32 (1998) 97-104
17. Veronesi U., Cascinelli N., Adamus J., et al. Thin stage 1 primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm. N Engl J Med 318 (1988) 1159-1162
18. Esmaeli B., Youssef A., Naderi A., et al. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group report. Ophthal Plast Reconstr Surg 19 (2003) 96-101
19. Elder D.E., Guerry IV D., Heiberger R.M., et al. Optimal resection margin for cutaneous malignant melanoma. Plast Reconstr Surg 71 (1983) 66-72
20. Breslow A., and Macht S.D. Optimal size of resection margins for thin cutaneous melanoma. Surg Gynecol Obstet 145 (1977) 691-692
21. Kelly J.W., Sagebiel R.W., Calderon W., et al. The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma. Ann Surg 200 (1984) 759-763
22. Yu L.L., and Heenan P.J. The morphological features of locally recurrent melanoma and cutaneous metastases of melanoma. Hum Pathol 30 (1999) 551-555
23. Bienert T.N., Trotter M.J., and Arlette J.P. Treatment of cutaneous melanoma of the face by Mohs micrographic surgery. J Cutan Med Surg 7 (2003) 25-30
24. Prieto V.G., Argenyi Z.B., Barnhill R.L., et al. Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions?. Am J Clin Pathol 120 (2003) 203-208
25. McGovern V.J. The classification of melanoma and its relationship with prognosis. Pathology 2 (1970) 85-98
26. Malhotra R., Chen C., Huilgol S.C., et al. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma. Ophthalmology 110 (2003) 2011-2018
27. Jacobs I.A., Chang C.K., DasGupta T.K., and George G.I. Role of sentinel lymph node biopsy in patients with thin (<1mm) primary melanoma. Ann Surg Oncol 10 (2003) 558-561
28. Nijhawan N., Ross M.I., Diba R., et al. Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center. Ophthal Plast Reconstr Surg 20 (2004) 291-295
29. Esmaeli B. Advances in the management of malignant tumors of the eyelid and conjunctiva: the role of sentinel lymph node biopsy. Int Ophthalmol Clin 42 2 (2002) 151-162
30. Esmaeli B. Sentinel node biopsy as a tool for accurate staging of eyelid and conjunctival malignancies. Curr Opin Ophthalmol 13 (2002) 317-323
31. Naylor M.F., Crowson N., Kuwahara R., et al. Treatment of lentigo maligna with topical imiquimod. Br J Dermatol 149 suppl (2003) 66-70
32. Powell A.M., Russsell-Jones R., and Barlow R.J. Topical imiquimod immunotherapy in the management of lentigo maligna. Clin Exp Dermatol 29 (2004) 15-21
33. Wolf I.H., Smolle J., Binder B., et al. Topical imiquimod in the treatment of metastatic melanoma to skin. Arch Dermatol 139 (2003) 273-276
34. Steinmann A., Funk J.O., Schuler G., and von den Driesch P. Topical imiquimod treatment of a cutaneous melanoma metastasis [letter]. J Am Acad Dermatol 43 (2000) 555-556
35. Borucki U., and Metze D. Topical treatment of lentigo maligna melanoma with imiquimod 5% cream [letter]. Dermatology 207 (2003) 326-328